Indirect Tax Archive

8. Schweizer MWST-Tagung 2023

Die Mehrwertsteuer ist im steten Wandel, wird immer transparenter und digitaler.

Für Sie als Entscheidungsträgerin und Entscheidungsträger wird es immer schwieriger, die gesetzlichen sowie behördlichen Vorgaben und Neuerungen sowohl effizient als auch kostengünstig einzuhalten. Dazu kommen die neue Geopolitik der Lieferketten, die Ukraine- und Energie-Krise sowie die wachsenden Spannungen des Westens mit China. All dies bringt umsatzsteuerliche Herausforderungen mit sich, die es zu meistern gilt. Gleichzeitig spielen künstliche Intelligenz sowie hoch entwickelte Chatbots wie ChatGPT eine immer wichtigere Rolle. Dieser absehbare Wandel birgt neue Chancen zur Prozessoptimierung.

Es gilt, alle diese Faktoren in Ihrem Unternehmen aufeinander abzustimmen, Chancen zu ergreifen und Hürden erfolgreich zu bewältigen.

ITX pharma virtual round table 2023

Dear all

Thank you for your interest in our ITX pharma virtual round table. This event will be held online on Wednesday, 31 May 2023, from 15:00 to 16:00 CEST.

After the success of our global ITX health industry convention last year, we will once again be discussing current developments, innovations and challenges that could have a major impact on the pharmaceutical, healthcare and life science industries from an indirect tax perspective.

PwC’s 7. Schweizer MWST-Tagung

Die Mehrwertsteuer, insbesondere im Pharma Bereich für Konzerne, KMUs und Start-ups, ist im steten Wandel und immer transparenter.

Für Sie als Entscheidungsträger im Pharma & Life Sciences Bereich, wird es immer schwieriger all die gesetzlichen und behördlichen Vorgaben und Neuerungen effizient als auch kostengünstig einzuhalten. Dazu kommen die anhaltenden Auswirkungen der COVID-19-Pandemie sowie die Ukraine-Krise, welche umsatzsteuerliche Herausforderungen mit sich bringen und die es zu meistern gilt. Gleichzeitig spielt Industrie 4.0 und die umfassende Digitalisierung in der industriellen Produktion eine immer wichtigere Rolle. Dieser absehbare Wandel bringt neue Chancen zur Prozessoptimierung.

Indirect Tax virtual round table

24 November 2021 or 25 November 2021

Dear Pharma and Life Science Colleagues,

Thank you for your interest in our virtual round table on ESG, regulation and rebates in the health industry. This event will be held online on Wednesday 24 November 2021 from 15:00 to 16:00 CET, and again on Thursday 25 November 2021 from 09:00 to 10:00 CET.

Using environmental, social and governance (ESG) metrics to evaluate companies and countries on their progress towards sustainability has become a hot topic all around the world. Alongside these issues, the health sector is also facing major regulatory challenges.

Webinar – Global Indirect Tax Health Industry Convention, 6 May 2021 2pm–6pm CEST

We are delighted to invite you to our virtual Global Indirect Tax Health Industry Convention “Succeeding through uncertainty” on Thursday 6 May 2021 from 2pm to 6pm CEST. We will discuss the latest hot topics in the pharma, healthcare and life science industry from an indirect tax perspective and beyond.

The incredible pace of change in indirect taxes in the pharma, healthcare and life sciences industry shows no sign of slowing down. Digital transformation, changes in supply chains due to the pandemic, Brexit and complex developments in EU legislation are just some of the factors that are currently having a major impact on this industry and affecting almost every aspect of our business lives.

Pharma & Life Sciences: 4 cutting edge digital tax & regulatory solutions

Discover PwC’s four cutting edge digital tax & regulatory solutions and how they can add value to your business, help you complying with new laws, stay up to date with upcoming changes in legislation and regulatory.

PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA

Dear pharma & life sciences colleagues,

It was a pleasure to welcome you to our webinar: PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA.

Attached below you can download the presentation.

PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA – Thursday 28. May 2020, 10:30 CEST

As the COVID-19 situation develops, tax and regulatory specialists within the pharmaceutical & life sciences industry are increasingly facing complex challenges. Efficient and pragmatic solutions have to be realised, with fewer resources, in line with the changing local legislation.

The exchange of information is the best practice in this industry to support and inspire you in your daily business.

Webinar on indirect tax issues in Precision Medicine

Dear all,

Happy to invite you to have a look to our latest PwC Webinar on precision medicines and the respective hot topics in the VAT field for the US, Europe, Switzerland and Asia. Continue reading Webinar on indirect tax issues in Precision Medicine

Webinar: Precision Medicine – Accurate Indirect Tax

I am pleased to invite you to our Webinar on Precision Medicine
and Accurate Indirect Tax

During this digital presentation our panel of experts will give you an overview of possible indirect tax implications within the pharma sector. This panel consists of many tax specialists of the pharmaceutical sector and PwC’s international indirect tax experts. Experts, who are dedicated to the pharmaceutical industry.

I will use my time slot to discuss the implications for Switzerland including which countries will be covered.

You will have the opportunity to exchange your experiences and views on the issue with other international leaders.

Date: November 6th 2018 November 8th 2018
Time: 10am – 11 am CET 12am – 1pm CET

More information and registration here